The following is the latest information from federal regulators as of 4:45 p.m. on Thursday, April 9.

Centers for Medicare & Medicaid Services

See an updated list of the section 1135 waivers CMS has granted to help states and health care providers respond to the COVID-19 crisis.

National Institutes of Health

The NIH has announced the launch of a clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with COVID-19.

Department of Health and Human Services


Food and Drug Administration

The FDA has published final guidance to health care professionals and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 and offers recommendations on the collection of COVID-19 convalescent plasma.